← Leaderboards
Cydney N Johnson
University Of Colorado Denver
$128,064
Attributed
$128,064
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $73.8K · FY2021–25$100K$75K$50K$25K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$128,064 · 2
By mechanism
F32$86,267 · 1
F31$41,797 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Boris Tabakoff$49,372,989
- Nancy Rumbaugh Whitesell$9,852,919
- Robert Freedman$18,290,612
- David R Grosshans$9,101,858
- Rajesh Agarwal$27,337,251
Others in their field
Other Emerging Leaders on “Antibiotics”
- Urs Ochsner · Crestone, Inc.$36,950,837
- Ryan Cirz · Revagenix, Inc.$35,410,554
- Daniel Pevear · Venatorx Pharmaceuticals, Inc.$24,789,028
- Bruce Blough · Research Triangle Institute$19,637,160
- Thomas Dick · Rbhs-New Jersey Medical School$15,241,285
- Steven Armen Boyd · Venatorx Pharmaceuticals, Inc.$13,685,544
Research focus
AntibioticsBiologyGenesPublishingGeneticAntibiotic TherapyCellsCytolysisInsightSpecificityPathogenInfectionBacteriaCell WallBiochemicalBacterial FitnessAntibiotic ResistanceAutolysisAnti-Bacterial AgentsAlternative TherapiesAdsorptionBindingAutolysinArea
Grant awards (4)
Mucin inhibits pneumococcal stationary phase autolysis$12,439
F32 · FY2025 · AI · contact PI
Mucin inhibits pneumococcal stationary phase autolysis$73,828
F32 · FY2024 · AI · contact PI
Molecular mechanisms of lytic bacteriophage infection of enterococci$7,814
F31 · FY2022 · AI · contact PI
Molecular mechanisms of lytic bacteriophage infection of enterococci$33,983
F31 · FY2021 · AI · contact PI